Improving the Use of Immunotherapy to Treat Liver Cancer
Improving the Use of Immunotherapy to Treat Liver Cancer
Recruiting · NCT07623265 · Registry updated 2026-06-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Improving the Use of Immunotherapy to Treat Liver Cancer | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Not applicable | 2026-06-03 | NCT07623265 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Flemish institute of biotechnology (VIB) | 3 |
| Universitaire Ziekenhuizen KU Leuven | 262 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AZ Delta | Roeselare | Belgium | 25 |
| AZ Groeninge | Kortrijk | Belgium | 18 |
| Jessa Ziekenhuis | Hasselt | Belgium | 18 |
| UZA | Antwerp | Belgium | 9 |